Abstract
A prospective study of the frequency, timing, etiology and risk factors of infections in renal transplant recipients during the first year after transplantation was conducted in 50 consecutive patients. Neither prophylaxis with trimethoprim-sulfamethoxazole nor antiviral prophylaxis was administered. Two hundred twenty-eight episodes of infection were registered (4.5 per patient), 19 of which were severe. Forty-seven percent of all infectious episodes occurred during the first two months after transplantation. The more frequent infections were bacterial (64 %), viral (22 %) and fungal (11 %).Escherichia coli was the most common agent isolated (n=36), followed by cytomegalovirus (n=32). Urinary tract infections were most common (n=144), especially asymptomatic bacteriuria (n=106). Surgical reintervention and the use of antilymphocytic globulins were associated with a higher frequency of severe infections (p<0.05), and invasive candidiasis was associated with allograft loss (p<0.03). Annual survival rates of patients and allografts were 100 % and 94 %, respectively. The frequency of mild infections was higher than that observed in other studies using bacterial or viral prophylaxis. Nevertheless, the number of severe infections and the survival rates of patients and allografts were similar to those reported in previous studies.
Similar content being viewed by others
References
Terasaki PI, Cecka JM, Lih E, Takemoto S, Cho Y, Gjertson D, Ogura K, Koyama H, Mitsuishi Y, Cohn M Overview. In: Terasaki PI, Cecka JM (ed): Clinical transplants 1991. University of California Los Angeles, Los Angeles, 1992, p.409–430.
Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K Cyclosporine A in patients receiving renal allografts from cadaver donors. Lancet 1978, ii: 1323–1327.
Cohen DJ, Loertscher R, Rubin MF, Tiney NL, Carpenter CB, Strom TB Cyclosporine: a new immunosuppresive agent for organ transplantation. Annals of Internal Medicine 1984, 101: 667–687.
Peterson PK, Andersen RC Infection in renal transplant recipients: current approaches to diagnosis, therapy and prevention. American Journal of Medicine 1986, 81, Supplement 1A: 2–10.
Hill MN, Grossman RA, Feldman HI, Hurwitz S, Dafoe DC Changes in causes of death after renal transplantation, 1966–1987. American Journal of Kidney Diseases 1991, 17: 512–518.
Gleaves CA, Smith TF, Shuster EA, Pearson GR Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. Journal of Clinical Microbiology 1984, 19: 917–919.
Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voges R A radioimmunoassay to measure cyclosporine A in plasma and serum samples. Journal of Immunoassay 1981, 2: 19–32.
Fox BC, Sollinger HW, Belzer FO, Maki DG A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. American Journal of Medicine 1990, 89: 255–274.
Peterson PK, Ferguson R, Fryd DS, Balfour HH, Rynasiewicz J, Simmons RL Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and envolving problem. Medicine 1982, 61: 360–372.
Rubin RH, Wolfson JS, Cosimi AB Infection in the renal transplant patient. American Journal of Medicine 1981, 70: 405–411.
Krieger JN, Tapia L, Stubendord WT, Stenzel KH, Rubin AL Urinary infection in kidney transplantation. Urology 1977, 9: 130–136.
Ramsey DE, Finch WT, Birtch AG Urinary tract infections in kidney transplant recipients. Archives of Surgery 1979, 114: 1022–1025.
Maki DG, Fox BC, Kuntz J, Sollinger HW, Belzer FO A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation. Side effects of trimethoprim-sulfamethoxazole, interaction with cyclosporine. Journal of Laboratory and Clinical Medicine 1992, 119: 11–24.
Lobo PI, Rudolf LE, Krieger JN Wound infections in renal transplant recipients as complication of urinary tract infections during allograft malfunction. Surgery 1982; 92: 491–496.
Rubin RH, Fang LS, Cosimi B, Herrin JT, Varga TA, Russell PS, Tolkoff-Rubin NE Usefulness of the antibody-coated bacteria assay in the management of urinary tract infection in the renal transplant patient. Transplantation 1979, 27: 18–20.
Byrd LH, Cheigh JS, Stenzel KH, Tapia L, Aronian J, Rubin AL Association betweenStreptococcus faecalis urinary tract infections and graft rejection in kidney transplantation. Lancet 1978; ii: 1167–1169.
García-Leoni MB, Martín-Scapa C, Rodeño P, Valderrábano F, Moreno S, Bouza E High incidence of tuberculosis in renal patients. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 283–285.
Gallis HA, Berman RA, Cate TR, Hamilton JD, Gunnells JC, Stickel DL Fungal infection following renal transplantation. Archives of Internal Medicine 1975, 135: 1163–1172.
Balfour HH, Chace BA, Stapletton JT, Simmons RL, Fryd DS A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. New England Journal of Medicine 1989, 320: 1381–1387.
Stoffel M, Squifflet JP, Pirson Y, Lamy M, Alexandre GP Effectiveness of oral acyclovir prophylaxis in renal transplant recipients. Transplantation Proceedings 1987, 19: 2190–2193.
Hardy AM, Wajszczuk CP, Suffredini AF, Hakala TR, Ho M Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. Journal of Infectious Diseases 1984, 149: 143–148.
Santiago-Delpin EA, Mora E, Gonzalez ZA, Morales-Otero LA, Bermudez R Factors in an outbreak ofPneumocystis carinii in a transplant unit. Transplantation Proceedings 1988, 20: 462–465.
Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L Successful intermittent chemoprophylaxis forPneumocystis carinii pneumonitis. New England Journal of Medicine 1987, 316: 1627–1632.
Ruskin J, LaRiviere M Low-dose co-trimoxazole for prevention ofPneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991, 337: 468–471.
Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, Tzakis AG, Starzl TB, Ho M Infection after liver transplantation. An analysis of 101 consecutive cases. Medicine 1988, 67: 132–143.
Oh CS, Stratta RJ, Fox BC, Sollinger HW, Belzer FO, Maki DG Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation 1988, 45: 68–73.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martinez-Marcos, F., Cisneros, J., Gentil, M. et al. Prospective study of renal transplant infections in 50 consecutive patients. Eur. J. Clin. Microbiol. Infect. Dis. 13, 1023–1028 (1994). https://doi.org/10.1007/BF02111821
Issue Date:
DOI: https://doi.org/10.1007/BF02111821